ASX:TRP

Tissue Repair (TRP) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Tissue Repair

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.

TRP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tissue Repair and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
7,283
Year Founded
N/A

Profitability

Net Income
$-3,280,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.03 million
Book Value
A$0.33 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.22
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (ASX:TRP) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners